Peripheral TDP-43 pathology in amyotrophic lateral sclerosis: toward a systemic proteinopathy
Acta Neuropathologica · 2026
DOI: 10.1007/s00401-026-03086-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Neuropathologica, 2026. Verfasst von Philippe Codron und 7 weiteren Autor:innen. Beteiligte Einrichtung: ALS Reference Center, Department of Neurology, University Hospital of Angers, Angers, France. philippe.codron@chu-angers.fr. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, TDP-43 Proteinopathies. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive degeneration of upper and lower motor neurons. Cytoplasmic accumulation of phosphorylated TAR DNA-binding protein 43 (pTDP-43) is the pathological hallmark of most ALS cases. While ALS has traditionally been viewed as a disease confined to the brain, spinal cord and motor nerves, recent studies have reported pTDP-43 pathology in multiple other tissues (skeletal and cardiac muscle, skin, minor salivary glands, gastrointestinal tract and lymph nodes), referred to as peripheral pathology. The detection of pTDP-43 beyond the nervous system suggests that ALS-associated TDP-43 proteinopathy may be more widespread than previously recognized and raises fundamental questions regarding the spatial and temporal landscape of ALS pathology. Peripheral pTDP-43 accumulation may reflect a systemic biological susceptibility affecting multiple tissues, propagation of pathological TDP-43 species between anatomical compartments, or a combination of both mechanisms. While its biological significance is yet to be determined, the presence of pTDP-43 in peripheral tissues broadens the current conceptual framework of ALS. It may also provide new opportunities for pathology-based biomarkers, therapeutic monitoring, and mechanistic studies aimed at understanding disease initiation and progression. However, current evidence is derived from small and methodologically heterogeneous cohorts, and peripheral pTDP-43 pathology is not restricted to ALS, emphasizing the need for larger standardized studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ALS Reference Center, Department of Neurology, University Hospital of Angers, Angers, France. philippe.codron@chu-angers.fr.
- University of Angers, Inserm U1083-CNRS 6015, MITOVASC, SFR ICAT, Angers, France. philippe.codron@chu-angers.fr.
- Neurobiology and Neuropathology, Department of Pathology, University Hospital of Angers, Angers, France. philippe.codron@chu-angers.fr.
- ALS Reference Center, Department of Neurology, University Hospital of Angers, Angers, France.
- University of Angers, Inserm U1083-CNRS 6015, MITOVASC, SFR ICAT, Angers, France.
- Université Claude Bernard Lyon1, CNRS UMR 5261, INSERM U1315, Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Lyon, France.
ORCID-Profile: Philippe Codron
Zitieren
APA
Codron, P., Miranda, M., Garnier, M., He, S., Gouju, J., Cassereau, J., Leblanc, P., & Letournel, F. (2026). Peripheral TDP-43 pathology in amyotrophic lateral sclerosis: toward a systemic proteinopathy. Acta Neuropathologica. https://doi.org/10.1007/s00401-026-03086-3
Vancouver
Codron P, Miranda M, Garnier M, He S, Gouju J, Cassereau J, et al. Peripheral TDP-43 pathology in amyotrophic lateral sclerosis: toward a systemic proteinopathy. Acta Neuropathologica. 2026. doi:10.1007/s00401-026-03086-3
BibTeX
@article{Codron2026,
author = {Codron, Philippe and Miranda, Marion and Garnier, Maelle and He, Shiyang and Gouju, Julien and Cassereau, Julien and Leblanc, Pascal and Letournel, Franck},
title = {Peripheral TDP-43 pathology in amyotrophic lateral sclerosis: toward a systemic proteinopathy},
journal = {Acta Neuropathologica},
year = {2026},
doi = {10.1007/s00401-026-03086-3}
}
EUVIMED